Medivir to participate at the Kempen Life Sciences Conference
Medivir to participate at the Kempen Life Sciences Conference News provided by Share this article Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the virtual meeting Kempen Life Sciences Conference - 2021 Thematic Virtual Series, on April 21. The presentation will be available via Medivirs website; www.medivir.com. For additional information, please contact Yilmaz Mahshid, CEO Medivir in brief Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where...